VPC-14228
CAS No. 19983-28-9
VPC-14228( VPC 14228 | VPC14228 )
Catalog No. M27801 CAS No. 19983-28-9
VPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 83 | In Stock |
|
| 5MG | 85 | In Stock |
|
| 10MG | 139 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 462 | In Stock |
|
| 100MG | 644 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVPC-14228
-
NoteResearch use only, not for human use.
-
Brief DescriptionVPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
-
DescriptionVPC-14228 is a specific AR-DBD inhibitor that acts by inhibiting both Y594A and Q592A mutants.
-
In Vitro——
-
In Vivo——
-
SynonymsVPC 14228 | VPC14228
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorIndoleamine 2,3-Dioxygenase (IDO)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number19983-28-9
-
Formula Weight246.33
-
Molecular FormulaC13H14N2OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (405.96 mM)
-
SMILESC1CN(CCO1)c1nc(cs1)-c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shenghua Wu, et al. Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application. WO 2017181849 A1.
molnova catalog
related products
-
UT-155
UT-155 is a selective and potent antagonist of the androgen receptor (AR) (Ki: 267 nM for UT-155 binding to AR-LBD).
-
LY305
LY305 (LY-305) is a non-steroidal selective androgen receptor modulator (SARM) with Ki of 2.03 nM.
-
BMS-641988
BMS-641988 is a potent, selective, nonsteroidal androgen receptor antagonist with Ki of 1.7 nM, MDA-MB-453 cell IC50 of 16 nM.
Cart
sales@molnova.com